Saturday, August 24, 2013

Amgen close to buying Onyx for $125 per share

Amgen Inc is close to buying Onyx Pharmaceuticals Inc for $125 per share, or more than $10 billion, in a deal that is expected to be announced as soon as Monday, two people familiar with the matter said ...

by via Yahoo! Finance: Top Stories

No comments:

Post a Comment